Sitosterol

Drug Profile

Sitosterol

Alternative Names: Beta-sitosterol; Harzol

Latest Information Update: 27 Jan 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hoyer
  • Class Phytosterols; Phytotherapies
  • Mechanism of Action Cholesterol inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Benign prostatic hyperplasia
  • Discontinued Hyperlipidaemia

Most Recent Events

  • 31 Dec 2002 Development discontinued for Hyperlipidaemia before 2003
  • 08 Aug 2000 A study has been added to the Men's Health therapeutic trials section
  • 19 Jul 1999 A meta-analysis has been added to the Men's Health therapeutic trials and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top